ENDRA Life Sciences Inc.

NASDAQ: NDRA · Real-Time Price · USD
4.47
0.03 (0.68%)
At close: Aug 15, 2025, 11:51 AM

ENDRA Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-9.77M -11.51M -8.82M -9.57M -9.89M -10.06M -11.89M -12.23M -13.26M -13.18M -12.99M -12.21M -11.82M -11.23M -10.38M -10.98M -10.67M
Depreciation & Amortization
196.08K 206.17K 221.06K 237.5K 260.08K 275.45K 281.97K 270.12K 253.08K 234.26K 220.16K 223.07K 227.76K 224.41K 242.02K 198.28K 176.62K
Stock-Based Compensation
337.47K 571.92K 717.8K 1.01M 1.08M 996.43K 1.04M 1.09M 1.15M 1.2M 1.32M 1.01M 700.52K 412.35K 1.13K 1.15K 1.26K
Other Working Capital
96.46K 97.22K 175.92K -85.86K 116.23K 83.37K -261.72K -224.84K 126.44K 222.8K -246.89K -634.74K -367.59K 17.15M 25.11M 25.97M 24.43M
Other Non-Cash Items
3.04M 3.52M 3.06M 2.41M 2.78M 2.65M 839.24K 1.06M 1.56M 2.45M 1.54M 1.38M 991.99K -177.66K 1.24M 1.44M 1.62M
Deferred Income Tax
n/a n/a -1.65M -1.91M -2.14M -2.49M -837.85K -1.06M -1.56M -1.22M -303.87K 184.11K 911.76K 911.76K n/a n/a n/a
Change in Working Capital
27.41K 134.08K -1.27M -857.01K -944.22K -923.32K 107.42K -245.85K -316.77K -1.03M -890.12K -1.19M -1.08M -1.26M -1.64M -592.19K -1.7M
Operating Cash Flow
-6.55M -7.4M -8.06M -9M -9.19M -9.55M -10.46M -11.11M -12.18M -12.77M -12.33M -11.83M -11.3M -11.12M -10.54M -9.93M -10.58M
Capital Expenditures
-6.28K -16K -22.88K -22.88K -33.88K -33.88K -65.56K -80.42K -140.22K -202.58K -164.01K -149.15K -89.35K -45K -109.85K -121.72K -121.72K
Cash Acquisitions
-3.2K n/a 9.16K 12.37K 12.37K 9.16K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a 3.2K 3.21K 3.21K 3.21K 9.16 n/a n/a n/a n/a n/a n/a n/a n/a n/a 23.73K 23.73K
Investing Cash Flow
-6.28K -12.8K -10.52K -10.52K -21.52K -24.72K -65.56K -80.42K -140.22K -202.58K -164.01K -149.15K -89.35K -45K -109.85K -97.98K -97.98K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 42.26K 42.26K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a -4.93K -5.77K -5.77K -5.77K -3.22K -5.08K -5.08K -5.08K -7.79K -126.16K -126.16K -126.16K -242.14K -516.62K -516.62K -516.62K
Other Financial Acitivies
6.61M 6.67M 7.68M 7.68M 1.09M 1.03M -7.78M -7.78M -7.8M -7.8M 121.07K 121.07K 121.07K 3.03M 3.42M 8.54M 8.85M
Financial Cash Flow
7.49M 7.81M 9.48M 10.59M 7.99M 7.52M 5.84M 4.73M 7.54M 8.4M 8.72M 9.22M 1.67M 13.4M 18.65M 23.32M 24.42M
Net Cash Flow
930.17K 395.57K 1.41M 1.58M -1.22M -2.06M -4.68M -6.46M -4.77M -4.57M -3.78M -2.77M -9.72M 2.23M 8M 13.29M 13.74M
Free Cash Flow
-6.56M -7.42M -8.08M -9.02M -9.22M -9.58M -10.53M -11.19M -12.32M -12.97M -12.5M -11.98M -11.39M -11.17M -10.65M -10.05M -10.7M